nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—CHRM5—GPCR ligand binding—PENK—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Aclidinium—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Aclidinium—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Aclidinium—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Aclidinium—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0024	0.0024	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0024	0.0024	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00234	0.00234	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Aclidinium—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00203	0.00203	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.002	0.002	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Aclidinium—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Aclidinium—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Aclidinium—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CHKB—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00119	0.00119	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CHKB—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CPT1B—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.001	0.001	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.001	0.001	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.000998	0.000998	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.000989	0.000989	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.000938	0.000938	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.000938	0.000938	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PENK—narcolepsy	0.000937	0.000937	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000909	0.000909	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.000906	0.000906	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000898	0.000898	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PENK—narcolepsy	0.000897	0.000897	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000878	0.000878	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000875	0.000875	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000867	0.000867	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000863	0.000863	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000863	0.000863	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00086	0.00086	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00086	0.00086	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000834	0.000834	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000831	0.000831	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000823	0.000823	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000797	0.000797	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000797	0.000797	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.000795	0.000795	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CPT1B—narcolepsy	0.000794	0.000794	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000787	0.000787	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000775	0.000775	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000772	0.000772	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000765	0.000765	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000763	0.000763	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000754	0.000754	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000728	0.000728	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000728	0.000728	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000725	0.000725	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000725	0.000725	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000718	0.000718	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000718	0.000718	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000709	0.000709	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000707	0.000707	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.0007	0.0007	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000699	0.000699	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000669	0.000669	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000661	0.000661	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000661	0.000661	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000659	0.000659	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000659	0.000659	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000652	0.000652	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000652	0.000652	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.000649	0.000649	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000632	0.000632	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00063	0.00063	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000624	0.000624	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000622	0.000622	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.00059	0.00059	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000565	0.000565	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000554	0.000554	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000554	0.000554	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000537	0.000537	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000535	0.000535	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00053	0.00053	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000471	0.000471	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.00047	0.00047	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000465	0.000465	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000438	0.000438	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000436	0.000436	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000432	0.000432	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000397	0.000397	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000396	0.000396	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000392	0.000392	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.00039	0.00039	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NPS—narcolepsy	0.00039	0.00039	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000389	0.000389	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000389	0.000389	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000385	0.000385	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000385	0.000385	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000348	0.000348	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000333	0.000333	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000235	0.000235	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000234	0.000234	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000232	0.000232	CbGpPWpGaD
